Status:
RECRUITING
Congenital Heart Disease GEnetic NEtwork Study (CHD GENES)
Lead Sponsor:
Children's Hospital Medical Center, Cincinnati
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Congenital Heart Defects
Eligibility:
All Genders
Up to 99 years
Brief Summary
Congenital heart defects (CHD) are the most common major human birth malformation, affecting \~8 per 1,000 live births. CHD are associated with significant morbidity and mortality, and are second only...
Eligibility Criteria
Inclusion
- • Signed consent form
Exclusion
- Isolated patent foramen ovale
- Isolated prematurity-associated patent ductus arteriosus
Key Trial Info
Start Date :
November 15 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
32000 Patients enrolled
Trial Details
Trial ID
NCT01196182
Start Date
November 15 2010
End Date
December 1 2025
Last Update
September 17 2025
Active Locations (15)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital Los Angeles
Los Angeles, California, United States, 90027
2
Stanford University
Palo Alto, California, United States, 94304
3
University of California, San Francisco
San Francisco, California, United States, 94158
4
Yale University
New Haven, Connecticut, United States, 06520